Targeting Lung Cancer Bad Actor
In the cancer world, a protein called Hsp90 is a bad actor. It helps a number of different cancers survive and thrive. An experimental medication may become Hsp90’s worst nightmare.
Gene Test Catches Tiny Cancers
A new genetic test, combined with CT screening, can identify aggressive lung cancer at an early stage. Results may help determine the best therapy options to help patients live longer.
Beta Blockers Help Block Cancer Spread
Radiation is a common method to kill or shrink cancer cells. Lung cancer patients taking heart medication during radiotherapy may have better results than those not taking these drugs.
Lung Cancer Medication Enobosarm Fast-Tracked by the FDA
GTx , Inc. today announced that the US Food and Drug Administration (FDA) has designated enobosarm ( GTx-024 ) for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer as a Fast Track development program.
CT Catches More Early Cancer Cases
Finding lung cancer early on can save lives, but currently there is not an approved method for screening. The percentage of early-stage lung cancers detected via CT scans, however, has risen.
Vaccine for Late-Stage Cancer Fails
Vaccines are showing promise as medication therapy for patients with advanced-stage lung cancer. A new vaccine, however, recently failed to extend the lives of certain cancer patients.
New Gene Test IDs Patients for Cancer Drug
Targeted therapy can do wonders. The trick is finding which patients have the genetic mutation or some other alteration that drugs can effectively target.
Chemo-Drug Combo Clobbers Cancer
Gene therapies to treat lung cancer are continuing to emerge. A new combination of drugs may help lung cancer patients live longer. Several gene mutations have been identified in lung cancer cells.
Targeted Cancer Therapy Casts Wider Net
Targeting cancer gene mutations has been changing the way non-small cell lung cancer ( NSCLC ) is treated. As scientists learn more about the genetic makeup of tumors, more personalized therapy has become available.
An Alternative When Cancer Grows
When non-small cell lung cancer ( NSCLC ) grows again after shrinking on targeted therapy, patients may turn to chemotherapy. Adding local therapy to targeted drugs could offer another solution.